Overview

Respiratory seasons frequently involve several pathogens circulating at once, and their symptoms overlap. The Innotek combination cassette addresses this by detecting three targets from a single nasopharyngeal swab: Influenza A virus antigen, Influenza B virus antigen, and Mycoplasma pneumoniae antigen. Built on immunochromatographic (lateral-flow) technology, it returns a qualitative result at the point of care without instrumentation. During co-circulation, rapid triage at the point of care shortens the time to an appropriate management decision.

How the Combined Cassette Works

Each target has its own labelled zone on the strip. After the swab sample is processed in the provided buffer, the liquid migrates along the membrane. If a target antigen is present, it binds labelled particles and accumulates at its specific line, producing a visible band. The design lets a clinician read three outcomes from one sample in minutes, conserving both specimen and staff time compared with running three separate tests. The shared sample also reduces patient discomfort and the consumable cost per resolved diagnosis.

Why Combining Mycoplasma Matters

Mycoplasma pneumoniae is distinctive among common respiratory pathogens because it lacks a cell wall, which is why beta-lactam antibiotics such as penicillins are ineffective against it. Clinically, mycoplasma infection can mimic viral influenza with fever and cough, so mistaking one for the other risks inappropriate therapy. Detecting it alongside flu A and flu B helps direct the right class of treatment and supports infection-control decisions during outbreaks. Timely differentiation also supports public-health surveillance by clarifying which pathogen is driving local transmission.

Sample Type and Intended Use

The test uses a nasopharyngeal swab and is intended as an in vitro qualitative screen, typically for professional use rather than unsupervised self-testing. A negative result does not rule out infection, and confirmation by molecular methods may be appropriate when clinical suspicion remains high. As with all antigen tests, performance depends on proper collection technique and the timing relative to symptom onset. Training staff in proper swab insertion depth improves both sensitivity and the reliability of the read result.

FAQ

Q: Can one swab really test for three pathogens? A: Yes. The cassette has separate detection zones for influenza A, influenza B, and Mycoplasma pneumoniae antigens, read from a single processed sample.

Q: Why include Mycoplasma pneumoniae in a flu test? A: Its symptoms overlap with flu and, lacking a cell wall, it needs different antibiotics, so identifying it guides appropriate therapy.

Q: Is this a laboratory or point-of-care test? A: It is an immunochromatographic assay suited to point-of-care use, though it is generally intended for trained professionals.

Q: Does a negative result exclude infection? A: No. Antigen tests have limits; high clinical suspicion may warrant molecular confirmation regardless of the cassette result.